New varieties of melanocytes identified, may lead to targeted melanoma treatments

Researchers have discovered different types of melanocytes, some of which are associated with subtypes of melanoma that predominantly affect people of colour. The authors of the paper predict this discovery may lead to more targeted treatments for melanoma, according to a press release.

Pliaglis returns to Canadian market

Dr. Julia Carroll, dermatologist and founder of Compass Dermatology in Toronto, recently spoke on the Skin Spectrum Podcast about topical anesthetic options for pain management and how she has reintroduced Pliaglis into her practice.

She spoke with Dr. Lisa Kellett, dermatologist and founder of DLK on Avenue in Toronto, who detailed how she avoids longer wait times by using the time it takes for topical anesthetics to take effect by educating and checking in with her patients.

Researchers link type 2 diabetes to increased prevalence of skin diseases

Researchers have found an increased prevalence of skin diseases in Chinese adults with type 2 diabetes mellitus (T2DM), compared to non-diabetic Chinese adults. The research suggested significant differences of disturbances of pigmentation and neurological and psychogenic dermatoses across patients with normal glucose tolerance (NGT), impaired glucose tolerance (IGT) and T2DM.